Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD
Released
Latest announcements
Ask a question
Your question will be sent privately to Cynata Therapeutics. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Cynata Therapeutics a question about this announcement.